| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/12/1997 | US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules |
| 08/12/1997 | US5656480 Compounds which inhibit HIV replication |
| 08/12/1997 | US5656478 Smooth muscle tissue formation in vivo using cultured smooth muscle cells combined with an extracellular matrix |
| 08/12/1997 | US5656465 Methods of in vivo gene delivery |
| 08/12/1997 | US5656464 Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and process for their preparation |
| 08/12/1997 | US5656457 DNA sequence for the unique sequence herpes simplex virus type 2-glycoprotein G protein and method of expressing said unique sequence of HSV-2gG |
| 08/12/1997 | US5656455 Adenylate cyclase stimulating factor |
| 08/12/1997 | US5656450 Stimulating bone growth by mixing the implant with 1,25-dihydroxy-vitamin d3 |
| 08/12/1997 | US5656447 Obtaining a sample of mammalian tissues or cells, fixing the sample, contacting with polyclonal antibodies to form a complex with quinolinic acid present in the fixed sample, determining level, location and source of quinolinic acid |
| 08/12/1997 | US5656444 Forming monoclonal antibody-oncofetal protein complex |
| 08/12/1997 | US5656431 Isolating and determining sequence of platelet activating factor acetylhydrolase gene from subject sample, comparing to sequence of wild-type gene, identifying difference to detect genetic lesion |
| 08/12/1997 | US5656423 Genetic engineering; urogenital cancer detection |
| 08/12/1997 | US5656301 Mixed with additional medicinal agent selected from fibronectin, laminin, antiviral and antiinflammatory agents and carrier |
| 08/12/1997 | US5656300 Topical compositions containing LYCD and minoxidil |
| 08/12/1997 | US5656297 Modulated release from biocompatible polymers |
| 08/12/1997 | US5656289 Pharmaceutical formulations that have a biologically active hydrophilic phase and a chylomicra-containing hydrophobic phase |
| 08/12/1997 | US5656287 Syneristic with antitumor, anticancer agents; mixture of phosphatidylcholine, cholesterol, dimyristoylphosphatidylcholine and cyclosporin |
| 08/12/1997 | US5656273 Administering; treats infection caused by helminth, schistosoma, and metazoan |
| 08/12/1997 | US5656272 Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| 08/12/1997 | US5656269 Peptide plasminogen activators |
| 08/12/1997 | US5656267 Implantable cells that alleviate chronic pain in humans |
| 08/12/1997 | US5656266 Activating antigens on b cells |
| 08/12/1997 | US5655652 Center dispense suture package |
| 08/12/1997 | CA2090562C Chitin-binding protein cb1, method of producing the same and use of the same |
| 08/12/1997 | CA1339269C Purification of and cloning of the gene for interleukin-2 receptor |
| 08/12/1997 | CA1339260C Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 08/12/1997 | CA1339256C Treatment of diseases associated with hiv-infections |
| 08/07/1997 | WO1997028280A1 Diagnostic method and apparatus |
| 08/07/1997 | WO1997028269A1 Transduced human hematopoietic stem cells |
| 08/07/1997 | WO1997028267A1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
| 08/07/1997 | WO1997028266A1 Human dnase resistant to actin inhibition |
| 08/07/1997 | WO1997028262A1 Lyst1 and lyst2 gene compositions and methods of use |
| 08/07/1997 | WO1997028258A1 Cells expressing both human cd4 and cxcr4 |
| 08/07/1997 | WO1997028255A1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
| 08/07/1997 | WO1997028251A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028190A1 Cytokine antagonists and agonists |
| 08/07/1997 | WO1997028189A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
| 08/07/1997 | WO1997028188A1 A g protein-coupled receptor with an enlarged extracellular domain |
| 08/07/1997 | WO1997028187A2 Multivalent chimeric peptides as microbicides |
| 08/07/1997 | WO1997028186A1 PURIFIED SR-p70 PROTEIN |
| 08/07/1997 | WO1997028185A1 Anti-microbial protein |
| 08/07/1997 | WO1997028184A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | WO1997028183A1 Peptide inhibitors of hematopoietic cell proliferation |
| 08/07/1997 | WO1997028182A1 Anti-inflammatory peptides derived from c-reactive protein |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028175A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 08/07/1997 | WO1997028172A1 Non-peptide peptidomimetics and related cyclic hexapeptides |
| 08/07/1997 | WO1997027876A1 Immunotherapy sensitization of cancer therapy |
| 08/07/1997 | WO1997027874A1 Use of angiogenic lipids for vascularizing tissue |
| 08/07/1997 | WO1997027873A1 Antibodies for modulating cd47-mediated neutrophil transmigration |
| 08/07/1997 | WO1997027872A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | WO1997027871A1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/07/1997 | WO1997027870A1 Preventives and remedies for thrombocytopenia |
| 08/07/1997 | WO1997027869A1 Method for treatment of benign prostatic hypertrophy |
| 08/07/1997 | WO1997027868A1 Ovulation triggering drugs |
| 08/07/1997 | WO1997027867A1 Protection of hemopoietic cells |
| 08/07/1997 | WO1997027866A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon |
| 08/07/1997 | WO1997027865A1 Prolactin antagonists and uses thereof |
| 08/07/1997 | WO1997027864A1 Cyclic peptide antifungal agents |
| 08/07/1997 | WO1997027863A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders |
| 08/07/1997 | WO1997027856A1 Remedies or preventives for aids |
| 08/07/1997 | WO1997027848A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS |
| 08/07/1997 | WO1997027841A1 Use of compositions comprising stabilized biologically effective compounds |
| 08/07/1997 | WO1997027840A1 Sustained delivery of an active agent using an implantable system |
| 08/07/1997 | WO1997027749A1 NITROSATED AND NITROSYLATED α-ADRENERGIC RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS AND THEIR USES |
| 08/07/1997 | WO1997027747A1 Cytostatin i |
| 08/07/1997 | WO1997021815A3 Antifungal proteins |
| 08/07/1997 | WO1997021811A3 Novel tyrosine kinase receptors and ligands |
| 08/07/1997 | WO1997017085A3 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 08/07/1997 | WO1997012985A3 Multi-functional hematopoietic receptor agonists |
| 08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
| 08/07/1997 | DE19703449A1 Stable, tissue compatible, injectable calcitonin solutions |
| 08/07/1997 | DE19604225A1 Composition comprises cyclo-hexen-beta-amino acid and alpha-amino acid |
| 08/07/1997 | DE19603668A1 Increasing immune response to tumour cells by increasing expression of TAP or LMP proteins |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2251537A1 Anti-microbial protein from macadamia integrifolia |
| 08/07/1997 | CA2245179A1 Remedies or preventives for aids |
| 08/07/1997 | CA2245165A1 Sensitization of her2/neu over-expressing cancer cells to chemotherapeutic drugs |
| 08/07/1997 | CA2245145A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | CA2245085A1 Protection of hemopoietic cells |
| 08/07/1997 | CA2244879A1 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 08/07/1997 | CA2244864A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
| 08/07/1997 | CA2244850A1 A g protein-coupled receptor with an enlarged extracellular domain |
| 08/07/1997 | CA2244841A1 Combined radiotherapy and immunotherapy to treat cancer |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2244744A1 Lyst1 and lyst2 gene compositions and methods of use |
| 08/07/1997 | CA2244730A1 Anti-inflammatory peptides derived from c-reactive protein |
| 08/07/1997 | CA2244728A1 Use of angiogenic lipids for vascularizing tissue |
| 08/07/1997 | CA2244727A1 Immunomodulatory methods using oligosaccharides |
| 08/07/1997 | CA2244696A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon |
| 08/07/1997 | CA2244675A1 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders |
| 08/07/1997 | CA2244673A1 Peptide inhibitors of hematopoietic cell proliferation |
| 08/07/1997 | CA2244238A1 Cyclic peptide antifungal agents |
| 08/07/1997 | CA2243986A1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/07/1997 | CA2218398A1 Ovulation triggering drugs |
| 08/07/1997 | CA2196964A1 G protein coupled receptor proteins, their production and use |
| 08/06/1997 | EP0787802A2 Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 08/06/1997 | EP0787800A2 Plasmid and plasmid vector from Lactobacillus helveticus |